A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy

Saved in:
Bibliographic Details
Published inEuropean urology open science (Online) Vol. 21; pp. S92 - S93
Main Authors Bamias, A., De Santis, M., Grande, E., Marina, M., Li, J-R., Puente, J., Izumi, K., Lee, J.L., Kose, F., Antonyan, I., Ding, B., Patel, H., Davis, I.
Format Journal Article
LanguageEnglish
Published Elsevier 01.11.2020
Online AccessGet full text

Cover

Loading…
More Information
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(20)36166-8